Share Price and Basic Stock Data
Last Updated: January 2, 2026, 5:30 pm
| PEG Ratio | 0.76 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DRA Consultants Ltd operates in the project consultancy and turnkey services industry, focusing on delivering comprehensive solutions for various projects. As of the latest data, the company’s stock price stood at ₹18.7, with a market capitalization of ₹20.6 Cr. Over the years, the company has experienced fluctuations in its revenue. For instance, sales reported for FY 2023 were ₹14.98 Cr, up from ₹15.04 Cr in FY 2022, marking a slight decline. However, the trailing twelve months (TTM) sales are recorded at ₹21.80 Cr, indicating a rebound in revenue generation. Quarterly revenue trends show a recovery trajectory, with sales rising from ₹8.01 Cr in Mar 2023 to ₹12.74 Cr in Mar 2024. This growth trajectory is essential for the company’s sustainability in a competitive market, showcasing its ability to recover from previous downturns and adapt to changing market demands.
Profitability and Efficiency Metrics
DRA Consultants’ profitability metrics present a mixed picture. The company reported a net profit of ₹2.67 Cr for the TTM period, with an earnings per share (EPS) of ₹2.45. The operating profit margin (OPM) stood at 17.97%, reflecting a solid operational performance compared to industry averages, which typically range from 10% to 20%. The return on equity (ROE) was recorded at 8.07%, while return on capital employed (ROCE) was at 11.7%, both indicating reasonable efficiency in utilizing shareholder funds and capital investments. The interest coverage ratio (ICR) at 17.70x confirms that the company is comfortably managing its financial obligations, given that it has no borrowings. However, the cash conversion cycle (CCC) of 145.41 days suggests that the company might face challenges in converting its investments into cash flow, which could impact liquidity in the short term.
Balance Sheet Strength and Financial Ratios
DRA Consultants exhibits a robust balance sheet with no borrowings, which is a significant strength in its financial structure. The total assets stood at ₹35.71 Cr, while total liabilities were at ₹37.47 Cr, indicating a relatively stable financial position. The reserves have consistently increased, reaching ₹22.81 Cr as of Sep 2025, showcasing the company’s ability to retain earnings and strengthen its equity base. The book value per share rose to ₹29.92, reflecting the company’s underlying asset value relative to its market price of ₹18.7, resulting in a price-to-book ratio of 0.83x, which is below the typical sector range and might suggest potential undervaluation. Furthermore, the current ratio of 5.98 indicates a strong liquidity position, which is crucial for meeting short-term obligations, while the quick ratio mirrors this strength, standing at 5.98 as well.
Shareholding Pattern and Investor Confidence
The shareholding pattern of DRA Consultants reveals a high level of promoter confidence, with promoters holding 73.02% of the equity, which has remained stable over the years. This significant stake indicates a strong commitment to the company’s long-term vision and strategy. The public shareholding stood at 26.99%, with the number of shareholders increasing to 423 as of Sep 2025, reflecting growing investor interest. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could indicate a lack of institutional support, which may affect market perceptions. This concentration of ownership could also pose risks in terms of governance and decision-making, as a small group of shareholders wields substantial influence over company policies. Investor confidence, therefore, hinges on the company’s ability to maintain transparency and deliver consistent financial performance.
Outlook, Risks, and Final Insight
The outlook for DRA Consultants appears cautiously optimistic, given its strong balance sheet and improving sales trajectory. However, the company faces several risks, including the volatility in project demand and potential delays in project execution, which could impact revenue stability. Additionally, the high cash conversion cycle indicates that the company may experience liquidity challenges if it cannot efficiently manage its receivables. On the upside, the absence of debt provides a cushion against financial strain, allowing for potential investments in growth opportunities without the burden of interest payments. The company’s ability to enhance operational efficiency and improve cash flows will be critical for sustaining growth. In scenarios of continued sales growth coupled with effective cost management, the company could see a significant uplift in profitability, thereby enhancing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fine Line Circuits Ltd | 46.4 Cr. | 96.5 | 109/52.4 | 221 | 18.7 | 0.00 % | 4.45 % | 2.30 % | 10.0 |
| Filtra Consultants & Engineers Ltd | 78.9 Cr. | 72.0 | 92.4/53.0 | 28.5 | 22.0 | 2.78 % | 16.5 % | 11.4 % | 10.0 |
| DRA Consultants Ltd | 20.6 Cr. | 18.7 | 39.7/14.1 | 7.70 | 30.8 | 0.00 % | 11.7 % | 8.07 % | 10.0 |
| Zodiac Energy Ltd | 461 Cr. | 305 | 563/287 | 22.5 | 66.8 | 0.25 % | 20.0 % | 27.5 % | 10.0 |
| Rites Ltd | 11,817 Cr. | 246 | 316/192 | 28.7 | 54.8 | 3.07 % | 21.8 % | 14.7 % | 10.0 |
| Industry Average | 3,092.86 Cr | 396.36 | 55.08 | 123.85 | 0.60% | 12.09% | 10.71% | 10.00 |
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.89 | 11.55 | 5.35 | 9.80 | 4.78 | 10.35 | 7.03 | 8.01 | 6.89 | 12.74 | 9.12 | 12.34 | 9.46 |
| Expenses | 6.97 | 11.26 | 5.05 | 7.80 | 4.16 | 8.34 | 5.64 | 6.83 | 5.65 | 10.59 | 7.42 | 10.10 | 7.76 |
| Operating Profit | 1.92 | 0.29 | 0.30 | 2.00 | 0.62 | 2.01 | 1.39 | 1.18 | 1.24 | 2.15 | 1.70 | 2.24 | 1.70 |
| OPM % | 21.60% | 2.51% | 5.61% | 20.41% | 12.97% | 19.42% | 19.77% | 14.73% | 18.00% | 16.88% | 18.64% | 18.15% | 17.97% |
| Other Income | 0.01 | 0.56 | 0.30 | 0.36 | 0.17 | 0.30 | 0.04 | 0.55 | 0.03 | 0.57 | 0.15 | 0.69 | 0.12 |
| Interest | 0.05 | 0.04 | 0.09 | 0.07 | 0.07 | 0.06 | 0.07 | 0.07 | 0.10 | 0.09 | 0.09 | 0.18 | 0.10 |
| Depreciation | 0.45 | 0.07 | 0.18 | 0.28 | 0.30 | 0.39 | 0.32 | 0.32 | 0.31 | 0.40 | 0.42 | 0.47 | 0.43 |
| Profit before tax | 1.43 | 0.74 | 0.33 | 2.01 | 0.42 | 1.86 | 1.04 | 1.34 | 0.86 | 2.23 | 1.34 | 2.28 | 1.29 |
| Tax % | 27.97% | 14.86% | 18.18% | 32.34% | 33.33% | 26.34% | 26.92% | 26.87% | 27.91% | 21.08% | 26.12% | 25.00% | 24.81% |
| Net Profit | 1.03 | 0.63 | 0.26 | 1.35 | 0.28 | 1.37 | 0.76 | 0.98 | 0.62 | 1.77 | 0.99 | 1.70 | 0.97 |
| EPS in Rs | 0.94 | 0.57 | 0.24 | 1.23 | 0.26 | 1.25 | 0.69 | 0.89 | 0.57 | 1.61 | 0.90 | 1.55 | 0.88 |
Last Updated: December 27, 2025, 5:35 am
Below is a detailed analysis of the quarterly data for DRA Consultants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 9.46 Cr.. The value appears to be declining and may need further review. It has decreased from 12.34 Cr. (Mar 2025) to 9.46 Cr., marking a decrease of 2.88 Cr..
- For Expenses, as of Sep 2025, the value is 7.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.10 Cr. (Mar 2025) to 7.76 Cr., marking a decrease of 2.34 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 2.24 Cr. (Mar 2025) to 1.70 Cr., marking a decrease of 0.54 Cr..
- For OPM %, as of Sep 2025, the value is 17.97%. The value appears to be declining and may need further review. It has decreased from 18.15% (Mar 2025) to 17.97%, marking a decrease of 0.18%.
- For Other Income, as of Sep 2025, the value is 0.12 Cr.. The value appears to be declining and may need further review. It has decreased from 0.69 Cr. (Mar 2025) to 0.12 Cr., marking a decrease of 0.57 Cr..
- For Interest, as of Sep 2025, the value is 0.10 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.18 Cr. (Mar 2025) to 0.10 Cr., marking a decrease of 0.08 Cr..
- For Depreciation, as of Sep 2025, the value is 0.43 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.47 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.29 Cr.. The value appears to be declining and may need further review. It has decreased from 2.28 Cr. (Mar 2025) to 1.29 Cr., marking a decrease of 0.99 Cr..
- For Tax %, as of Sep 2025, the value is 24.81%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Mar 2025) to 24.81%, marking a decrease of 0.19%.
- For Net Profit, as of Sep 2025, the value is 0.97 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Mar 2025) to 0.97 Cr., marking a decrease of 0.73 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.88. The value appears to be declining and may need further review. It has decreased from 1.55 (Mar 2025) to 0.88, marking a decrease of 0.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.94 | 9.94 | 15.90 | 16.54 | 17.13 | 22.32 | 20.17 | 14.96 | 15.04 | 14.98 | 19.07 | 20.91 | 21.80 |
| Expenses | 7.67 | 7.57 | 12.12 | 12.97 | 12.87 | 18.03 | 17.65 | 12.65 | 12.42 | 12.41 | 15.68 | 16.97 | 17.86 |
| Operating Profit | 2.27 | 2.37 | 3.78 | 3.57 | 4.26 | 4.29 | 2.52 | 2.31 | 2.62 | 2.57 | 3.39 | 3.94 | 3.94 |
| OPM % | 22.84% | 23.84% | 23.77% | 21.58% | 24.87% | 19.22% | 12.49% | 15.44% | 17.42% | 17.16% | 17.78% | 18.84% | 18.07% |
| Other Income | 0.01 | 0.08 | 0.20 | 0.45 | 0.31 | 0.42 | 0.26 | 0.65 | 0.47 | 0.58 | 0.60 | 0.84 | 0.81 |
| Interest | 0.04 | 0.18 | 0.34 | 0.17 | 0.19 | 0.18 | 0.09 | 0.16 | 0.12 | 0.13 | 0.19 | 0.27 | 0.28 |
| Depreciation | 0.23 | 0.50 | 0.33 | 0.30 | 0.48 | 0.62 | 0.53 | 0.46 | 0.69 | 0.64 | 0.71 | 0.90 | 0.90 |
| Profit before tax | 2.01 | 1.77 | 3.31 | 3.55 | 3.90 | 3.91 | 2.16 | 2.34 | 2.28 | 2.38 | 3.09 | 3.61 | 3.57 |
| Tax % | 32.84% | 32.77% | 34.44% | 35.49% | 26.15% | -26.85% | 23.15% | 30.77% | 27.19% | 26.89% | 22.98% | 25.48% | |
| Net Profit | 1.35 | 1.19 | 2.16 | 2.29 | 2.88 | 4.96 | 1.65 | 1.61 | 1.65 | 1.74 | 2.38 | 2.69 | 2.67 |
| EPS in Rs | 13,500.00 | 11,900.00 | 21,600.00 | 2.09 | 2.63 | 4.52 | 1.50 | 1.47 | 1.50 | 1.59 | 2.17 | 2.45 | 2.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.85% | 81.51% | 6.02% | 25.76% | 72.22% | -66.73% | -2.42% | 2.48% | 5.45% | 36.78% | 13.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | 93.36% | -75.49% | 19.75% | 46.46% | -138.96% | 64.31% | 4.91% | 2.97% | 31.33% | -23.76% |
DRA Consultants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 1% |
| 3 Years: | 13% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 7% |
| 3 Years: | 20% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | -16% |
| 1 Year: | -66% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:46 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 |
| Reserves | 6.44 | 7.57 | 10.10 | 4.39 | 7.26 | 10.13 | 11.78 | 13.39 | 15.04 | 16.78 | 19.16 | 21.85 | 22.81 |
| Borrowings | 0.19 | 0.13 | 0.00 | 0.15 | 0.52 | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 3.80 | 3.28 | 6.74 | 6.27 | 3.55 | 6.52 | 5.80 | 6.66 | 6.44 | 3.63 | 3.82 | 2.89 | 3.69 |
| Total Liabilities | 10.44 | 10.99 | 16.85 | 21.78 | 22.30 | 27.74 | 28.56 | 31.02 | 32.45 | 31.38 | 33.95 | 35.71 | 37.47 |
| Fixed Assets | 0.82 | 0.73 | 1.19 | 0.99 | 1.39 | 1.20 | 0.94 | 7.49 | 7.24 | 6.71 | 7.26 | 6.99 | 6.91 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.37 | 0.86 | 4.70 | 4.12 | 5.39 | 7.64 | 11.88 | 8.14 | 8.86 | 10.03 | 10.37 | 10.23 | 11.00 |
| Other Assets | 9.25 | 9.40 | 10.96 | 16.67 | 15.52 | 18.90 | 15.74 | 15.39 | 16.35 | 14.64 | 16.32 | 18.49 | 19.56 |
| Total Assets | 10.44 | 10.99 | 16.85 | 21.78 | 22.30 | 27.74 | 28.56 | 31.02 | 32.45 | 31.38 | 33.95 | 35.71 | 37.47 |
Below is a detailed analysis of the balance sheet data for DRA Consultants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.97 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.97 Cr..
- For Reserves, as of Sep 2025, the value is 22.81 Cr.. The value appears strong and on an upward trend. It has increased from 21.85 Cr. (Mar 2025) to 22.81 Cr., marking an increase of 0.96 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.89 Cr. (Mar 2025) to 3.69 Cr., marking an increase of 0.80 Cr..
- For Total Liabilities, as of Sep 2025, the value is 37.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.71 Cr. (Mar 2025) to 37.47 Cr., marking an increase of 1.76 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.91 Cr.. The value appears to be declining and may need further review. It has decreased from 6.99 Cr. (Mar 2025) to 6.91 Cr., marking a decrease of 0.08 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.23 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 0.77 Cr..
- For Other Assets, as of Sep 2025, the value is 19.56 Cr.. The value appears strong and on an upward trend. It has increased from 18.49 Cr. (Mar 2025) to 19.56 Cr., marking an increase of 1.07 Cr..
- For Total Assets, as of Sep 2025, the value is 37.47 Cr.. The value appears strong and on an upward trend. It has increased from 35.71 Cr. (Mar 2025) to 37.47 Cr., marking an increase of 1.76 Cr..
Notably, the Reserves (22.81 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.08 | 2.24 | 3.78 | 3.42 | 3.74 | 4.17 | 2.51 | 2.31 | 2.62 | 2.57 | 3.39 | 3.94 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 257.41 | 216.28 | 118.91 | 205.45 | 198.16 | 129.35 | 130.11 | 175.18 | 197.55 | 228.31 | 183.94 | 145.41 |
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 257.41 | 216.28 | 118.91 | 205.45 | 198.16 | 129.35 | 130.11 | 175.18 | 197.55 | 228.31 | 183.94 | 145.41 |
| Working Capital Days | 173.32 | 15.79 | 77.82 | 193.75 | 210.09 | 143.25 | 144.95 | 136.14 | 199.73 | 197.85 | 172.26 | 180.49 |
| ROCE % | 33.61% | 27.18% | 40.85% | 29.04% | 23.88% | 20.47% | 11.60% | 10.31% | 8.93% | 9.08% | 11.16% | 11.69% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.45 | 2.17 | 1.58 | 1.51 | 1.47 |
| Diluted EPS (Rs.) | 2.45 | 2.17 | 1.58 | 1.51 | 1.47 |
| Cash EPS (Rs.) | 3.27 | 2.82 | 2.17 | 2.14 | 1.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.92 | 27.47 | 25.30 | 23.71 | 22.21 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.92 | 27.47 | 25.30 | 23.71 | 22.21 |
| Revenue From Operations / Share (Rs.) | 19.56 | 17.89 | 13.71 | 13.79 | 13.81 |
| PBDIT / Share (Rs.) | 4.36 | 3.63 | 2.88 | 2.82 | 2.69 |
| PBIT / Share (Rs.) | 3.54 | 2.98 | 2.29 | 2.19 | 2.27 |
| PBT / Share (Rs.) | 3.29 | 2.81 | 2.17 | 2.07 | 2.13 |
| Net Profit / Share (Rs.) | 2.45 | 2.17 | 1.58 | 1.50 | 1.47 |
| PBDIT Margin (%) | 22.27 | 20.30 | 20.97 | 20.42 | 19.48 |
| PBIT Margin (%) | 18.08 | 16.67 | 16.69 | 15.84 | 16.45 |
| PBT Margin (%) | 16.82 | 15.73 | 15.79 | 15.03 | 15.42 |
| Net Profit Margin (%) | 12.54 | 12.12 | 11.53 | 10.91 | 10.66 |
| Return on Networth / Equity (%) | 8.20 | 7.90 | 6.25 | 6.34 | 6.62 |
| Return on Capital Employeed (%) | 11.82 | 10.86 | 9.04 | 9.21 | 10.22 |
| Return On Assets (%) | 7.54 | 7.01 | 5.54 | 5.09 | 5.20 |
| Asset Turnover Ratio (%) | 0.61 | 0.60 | 0.47 | 0.47 | 0.50 |
| Current Ratio (X) | 5.98 | 3.96 | 3.69 | 2.37 | 2.01 |
| Quick Ratio (X) | 5.98 | 3.96 | 3.69 | 2.37 | 2.01 |
| Interest Coverage Ratio (X) | 17.70 | 21.45 | 23.54 | 25.27 | 18.96 |
| Interest Coverage Ratio (Post Tax) (X) | 10.96 | 13.81 | 13.95 | 14.51 | 11.37 |
| Enterprise Value (Cr.) | 23.32 | 25.16 | 20.39 | 14.20 | 8.11 |
| EV / Net Operating Revenue (X) | 1.09 | 1.28 | 1.36 | 0.93 | 0.53 |
| EV / EBITDA (X) | 4.88 | 6.31 | 6.46 | 4.60 | 2.75 |
| MarketCap / Net Operating Revenue (X) | 1.27 | 1.40 | 1.45 | 0.97 | 0.65 |
| Price / BV (X) | 0.83 | 0.91 | 0.78 | 0.56 | 0.40 |
| Price / Net Operating Revenue (X) | 1.27 | 1.40 | 1.45 | 0.97 | 0.65 |
| EarningsYield | 0.09 | 0.08 | 0.07 | 0.11 | 0.16 |
After reviewing the key financial ratios for DRA Consultants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 5. It has increased from 2.17 (Mar 24) to 2.45, marking an increase of 0.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 5. It has increased from 2.17 (Mar 24) to 2.45, marking an increase of 0.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.27. This value is within the healthy range. It has increased from 2.82 (Mar 24) to 3.27, marking an increase of 0.45.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.92. It has increased from 27.47 (Mar 24) to 29.92, marking an increase of 2.45.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.92. It has increased from 27.47 (Mar 24) to 29.92, marking an increase of 2.45.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.56. It has increased from 17.89 (Mar 24) to 19.56, marking an increase of 1.67.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.36. This value is within the healthy range. It has increased from 3.63 (Mar 24) to 4.36, marking an increase of 0.73.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.54. This value is within the healthy range. It has increased from 2.98 (Mar 24) to 3.54, marking an increase of 0.56.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.29. This value is within the healthy range. It has increased from 2.81 (Mar 24) to 3.29, marking an increase of 0.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.45. This value is within the healthy range. It has increased from 2.17 (Mar 24) to 2.45, marking an increase of 0.28.
- For PBDIT Margin (%), as of Mar 25, the value is 22.27. This value is within the healthy range. It has increased from 20.30 (Mar 24) to 22.27, marking an increase of 1.97.
- For PBIT Margin (%), as of Mar 25, the value is 18.08. This value is within the healthy range. It has increased from 16.67 (Mar 24) to 18.08, marking an increase of 1.41.
- For PBT Margin (%), as of Mar 25, the value is 16.82. This value is within the healthy range. It has increased from 15.73 (Mar 24) to 16.82, marking an increase of 1.09.
- For Net Profit Margin (%), as of Mar 25, the value is 12.54. This value exceeds the healthy maximum of 10. It has increased from 12.12 (Mar 24) to 12.54, marking an increase of 0.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.20. This value is below the healthy minimum of 15. It has increased from 7.90 (Mar 24) to 8.20, marking an increase of 0.30.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.82. This value is within the healthy range. It has increased from 10.86 (Mar 24) to 11.82, marking an increase of 0.96.
- For Return On Assets (%), as of Mar 25, the value is 7.54. This value is within the healthy range. It has increased from 7.01 (Mar 24) to 7.54, marking an increase of 0.53.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.61. It has increased from 0.60 (Mar 24) to 0.61, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 5.98. This value exceeds the healthy maximum of 3. It has increased from 3.96 (Mar 24) to 5.98, marking an increase of 2.02.
- For Quick Ratio (X), as of Mar 25, the value is 5.98. This value exceeds the healthy maximum of 2. It has increased from 3.96 (Mar 24) to 5.98, marking an increase of 2.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 17.70. This value is within the healthy range. It has decreased from 21.45 (Mar 24) to 17.70, marking a decrease of 3.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 13.81 (Mar 24) to 10.96, marking a decrease of 2.85.
- For Enterprise Value (Cr.), as of Mar 25, the value is 23.32. It has decreased from 25.16 (Mar 24) to 23.32, marking a decrease of 1.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.28 (Mar 24) to 1.09, marking a decrease of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 5. It has decreased from 6.31 (Mar 24) to 4.88, marking a decrease of 1.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.27, marking a decrease of 0.13.
- For Price / BV (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.83, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.27, marking a decrease of 0.13.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DRA Consultants Ltd:
- Net Profit Margin: 12.54%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.82% (Industry Average ROCE: 12.09%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.2% (Industry Average ROE: 10.71%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 10.96
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 5.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 7.7 (Industry average Stock P/E: 55.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.54%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Project Consultancy/Turnkey | Plot No 58, Nagpur Maharashtra 440005 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh Chhaganlal Rathi | Chairman & Director |
| Mr. Aditya Dinesh Rathi | Managing Director |
| Mrs. Uma Dinesh Rathi | Executive Director |
| Ms. Siddhi Dinesh Rathi | Non Executive Director |
| Mr. Manavendra Jayapal | Independent Director |
| Mrs. Renuka Saurabh Borole | Independent Director |
FAQ
What is the intrinsic value of DRA Consultants Ltd?
DRA Consultants Ltd's intrinsic value (as of 04 January 2026) is ₹15.62 which is 16.47% lower the current market price of ₹18.70, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹20.6 Cr. market cap, FY2025-2026 high/low of ₹39.7/14.1, reserves of ₹22.81 Cr, and liabilities of ₹37.47 Cr.
What is the Market Cap of DRA Consultants Ltd?
The Market Cap of DRA Consultants Ltd is 20.6 Cr..
What is the current Stock Price of DRA Consultants Ltd as on 04 January 2026?
The current stock price of DRA Consultants Ltd as on 04 January 2026 is ₹18.7.
What is the High / Low of DRA Consultants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DRA Consultants Ltd stocks is ₹39.7/14.1.
What is the Stock P/E of DRA Consultants Ltd?
The Stock P/E of DRA Consultants Ltd is 7.70.
What is the Book Value of DRA Consultants Ltd?
The Book Value of DRA Consultants Ltd is 30.8.
What is the Dividend Yield of DRA Consultants Ltd?
The Dividend Yield of DRA Consultants Ltd is 0.00 %.
What is the ROCE of DRA Consultants Ltd?
The ROCE of DRA Consultants Ltd is 11.7 %.
What is the ROE of DRA Consultants Ltd?
The ROE of DRA Consultants Ltd is 8.07 %.
What is the Face Value of DRA Consultants Ltd?
The Face Value of DRA Consultants Ltd is 10.0.